| Literature DB >> 30745493 |
Yunqing Yang1, Atsushi Hozawa1,2, Mana Kogure1,2, Akira Narita1,2, Takumi Hirata1,2, Tomohiro Nakamura1,2, Naho Tsuchiya1,2, Naoki Nakaya1,2, Toshiharu Ninomiya3, Nagako Okuda4, Aya Kadota5,6, Takayoshi Ohkubo7, Tomonori Okamura8, Hirotsugu Ueshima5,6, Akira Okayama9, Katsuyuki Miura5,6.
Abstract
BACKGROUND: It has been reported that chronic inflammation may play an important role in the pathogenesis of several serious diseases and could be modulated by diet. Recently, the Dietary Inflammatory Index (DII®) was developed to assess the inflammatory potential of the overall diet. The DII has been reported as relevant to various diseases but has not been validated in Japanese. Thus, in the present study, we analyzed the relationship between DII scores and high-sensitivity C-reactive protein (hs-CRP) levels in a Japanese population.Entities:
Keywords: CRP; Japanese; Japanese diet; dietary inflammatory index; inflammation
Year: 2019 PMID: 30745493 PMCID: PMC6949183 DOI: 10.2188/jea.JE20180156
Source DB: PubMed Journal: J Epidemiol ISSN: 0917-5040 Impact factor: 3.211
Figure 1. Flow diagram of study population. Participants were excluded for the following reasons: 1) younger than 20 years old or absence of blood examination; 2) without informed consent; 3) data could not be utilized; 4) having incomplete data on food and nutrient intake; 5) calorie intake less than 500 kcal/d or more than 5,000 kcal/d; 6) high-sensitivity C-reactive protein level >3 mg/L; 7) physical activity unknown; 8) smoking status unknown; 9) BMI could not be calculated.
Characteristics across quartiles of Dietary Inflammatory Index (DII®) scores
| DII quartilesa | |||||||||
| Q1 | Q2 | Q3 | Q4 | ||||||
| Characteristics | % | % | % | % | |||||
| −1.38 | 0.33 | 1.55 | 2.85 | <0.01 | |||||
| 239 | 37.2 | 253 | 39.4 | 274 | 42.6 | 320 | 49.8 | <0.01 | |
| 404 | 62.8 | 390 | 60.7 | 369 | 57.4 | 323 | 50.2 | ||
| 64.4 (12.3) | 61.3 (14.8) | 56.1 (16.5) | 52.3 (16.5) | <0.01 | |||||
| 38 | 5.9 | 42 | 6.5 | 32 | 5.0 | 55 | 8.6 | 0.03 | |
| 448 | 69.7 | 441 | 68.6 | 430 | 66.9 | 400 | 62.2 | ||
| 157 | 24.4 | 160 | 24.9 | 181 | 28.2 | 188 | 29.2 | ||
| 51 | 7.9 | 71 | 11.0 | 110 | 17.1 | 162 | 25.2 | <0.01 | |
| 111 | 17.3 | 131 | 20.4 | 124 | 19.3 | 132 | 20.5 | ||
| 481 | 74.8 | 441 | 68.6 | 409 | 63.6 | 349 | 54.3 | ||
| 37.3 (8.0) | 37.0 (7.9) | 37.5 (9.0) | 38.6 (9.6) | <0.01 | |||||
| 126 | 19.6 | 115 | 17.9 | 87 | 13.6 | 63 | 9.8 | <0.01 | |
| 517 | 80.4 | 528 | 82.1 | 555 | 86.5 | 580 | 90.2 | ||
| 513 | 80.0 | 511 | 79.6 | 483 | 75.4 | 456 | 71.6 | <0.01 | |
| 128 | 20.0 | 131 | 20.4 | 158 | 24.7 | 181 | 28.4 | ||
| 167 | 26.0 | 162 | 25.2 | 145 | 22.6 | 142 | 22.1 | 0.47 | |
| 279 | 43.4 | 267 | 41.5 | 296 | 46.1 | 288 | 44.9 | ||
| 197 | 30.6 | 214 | 33.3 | 201 | 31.3 | 212 | 33.0 | ||
| 16. (10.1) | 15.7 (14.5) | 14.6 (12.6) | 14.3 (18.7) | <0.01 | |||||
BMI, body mass index; METs, metabolic equivalents; SD, standard deviation.
aDII quartiles: −5.04 ≤ Q1 < −0.38; −0.38 ≤ Q2 < 0.91; 0.91 ≤ Q3 < 2.18; 2.18 ≤ Q4 ≤ 4.94.
bSample size: antilipidemic agent use = 2,571; marital status = 2,561; education = 2,570; equivalent household expenditure = 2,380.
Food intakes across quartiles of Dietary Inflammatory Index (DII®) scoresa
| Food item (g) | Q1 | SD | Q2 | SD | Q3 | SD | Q4 | SD |
| Cereal | 393.28 | 145.20 | 425.79 | 156.73 | 449.87 | 167.15 | 507.25 | 191.50 |
| Potato | 80.32 | 84.22 | 61.00 | 68.13 | 52.05 | 62.93 | 41.73 | 53.20 |
| Sugar and Sweeteners | 7.89 | 8.65 | 7.31 | 7.88 | 6.96 | 8.81 | 7.77 | 11.46 |
| Bean | 99.18 | 90.08 | 75.14 | 81.23 | 53.39 | 64.72 | 41.92 | 59.39 |
| Nut and seed | 4.45 | 10.23 | 2.98 | 10.01 | 1.78 | 6.84 | 1.24 | 5.06 |
| Vegetable | 459.00 | 179.31 | 329.42 | 145.18 | 258.89 | 134.71 | 179.58 | 111.20 |
| Fruit | 190.88 | 150.37 | 138.68 | 129.31 | 98.97 | 113.66 | 61.13 | 93.60 |
| Mushrooms | 28.83 | 35.24 | 22.05 | 29.48 | 15.68 | 24.44 | 11.57 | 20.95 |
| Seaweeds | 19.13 | 31.83 | 11.94 | 20.51 | 11.31 | 20.83 | 8.04 | 16.82 |
| Seafood | 107.93 | 76.29 | 89.63 | 71.39 | 79.91 | 77.64 | 57.26 | 66.25 |
| Meat | 63.20 | 57.03 | 68.38 | 59.69 | 78.28 | 67.28 | 92.12 | 80.79 |
| Egg | 33.69 | 30.66 | 37.99 | 32.36 | 36.65 | 34.39 | 34.73 | 33.49 |
| Milk | 118.36 | 122.92 | 111.36 | 127.04 | 100.23 | 132.26 | 93.13 | 125.75 |
| Fat and oil | 8.92 | 8.44 | 8.95 | 8.44 | 10.31 | 9.73 | 10.58 | 8.83 |
| Confectionery | 19.86 | 34.24 | 26.35 | 43.89 | 26.04 | 44.60 | 36.36 | 56.19 |
| Preferred beverage | 766.11 | 469.28 | 720.00 | 471.81 | 702.66 | 511.27 | 720.13 | 522.49 |
| Seasoning and Spice | 99.87 | 146.78 | 92.96 | 81.50 | 84.59 | 78.21 | 91.88 | 95.38 |
| Nutrients supplementary food | 19.03 | 58.99 | 18.39 | 61.35 | 18.22 | 69.16 | 10.63 | 62.21 |
SD, standard deviation.
aDII quartiles: −5.04 ≤ Q1 < −0.38; −0.38 ≤ Q2 < 0.91; 0.91 ≤ Q3 < 2.18; 2.18 ≤ Q4 ≤ 4.94.
Multiple linear regression analysis between log-transformed hs-CRP and other variables, stratified by sexa
| Men | Women | Total | |||||||||||||
| Variable | Standardized β | β | 95% CI | Standardized β | β | 95% CI | Standardized β | β | 95% CI | ||||||
| DII scoreb | 0.05 | 0.01 | −0.003 | 0.02 | 0.14 | 0.06 | 0.01 | 0.001 | 0.02 | 0.02 | 0.05 | 0.01 | 0.003 | 0.02 | <0.01 |
| Ageb | 0.13 | 0.003 | 0.001 | 0.004 | <0.01 | 0.13 | 0.002 | 0.002 | 0.003 | <0.01 | 0.14 | 0.003 | 0.002 | 0.003 | <0.01 |
| BMIb | 0.27 | 0.03 | 0.02 | 0.03 | <0.01 | 0.37 | 0.03 | 0.03 | 0.04 | <0.01 | 0.33 | 0.03 | 0.026 | 0.032 | <0.01 |
| Sex (ref. women) | 0.007 | 0.004 | −0.02 | 0.03 | 0.76 | ||||||||||
| Smoking (ref. never-smokers) | |||||||||||||||
| Former smokers | 0.03 | 0.02 | −0.02 | 0.06 | 0.30 | 0.04 | 0.05 | −0.01 | 0.11 | 0.07 | 0.03 | 0.02 | −0.01 | 0.05 | 0.17 |
| Current smokers | 0.10 | 0.07 | 0.03 | 0.12 | <0.01 | −0.001 | −0.001 | −0.06 | 0.06 | 0.97 | 0.06 | 0.05 | 0.02 | 0.09 | <0.01 |
| Physical activityb | −0.06 | −0.002 | −0.003 | −0.00001 | 0.06 | −0.06 | −0.003 | −0.005 | −0.001 | 0.01 | −0.06 | −0.002 | −0.003 | −0.001 | <0.01 |
BMI, body mass index; CI, confidence interval; hs-CRP, highly sensitive C-reactive protein.
ahs-CRP, high-sensitivity C-reactive protein; DII, Dietary inflammatory index; energy was adjusted by residual method.
bContinuous variable.
cAdjusted for age, BMI, smoking status, and physical activity.
dAdjusted for age, BMI, sex, smoking status, and physical activity.
Multiple linear regression analysis between log-transformed hs-CRP and Dietary Inflammatory Index (DII®) scores, stratified by age and sex
| Men | Women | Total | |||||||
| Age, years | standardized β | standardized β | standardized β | ||||||
| <45 | 212 | −0.05 | 0.42 | 361 | 0.11 | 0.02 | 573 | 0.05 | 0.21 |
| 45–54 | 135 | 0.05 | 0.53 | 202 | 0.02 | 0.75 | 337 | 0.03 | 0.51 |
| 55–64 | 255 | 0.10 | 0.12 | 336 | −0.04 | 0.50 | 591 | 0.03 | 0.43 |
| 65–74 | 309 | 0.01 | 0.91 | 369 | 0.08 | 0.11 | 678 | 0.05 | 0.19 |
| ≥75 | 175 | 0.04 | 0.61 | 218 | 0.14 | 0.04 | 393 | 0.10 | 0.05 |
| Total | 1,086 | 0.05 | 0.14 | 1,486 | 0.06 | 0.02 | 2,572 | 0.05 | <0.01 |
hs-CRP, high-sensitivity C-reactive protein.
aAdjusted for age, smoking status, BMI, and physical activity.
bAdjusted for age, sex, smoking status, BMI, and physical activity.
Previous research on association between Dietary Inflammatory Index (DII®) and CRP
| Author | Year | Country or | Number of food | Inflammatory | Risk estimate |
| 2018 | Iran | 31 | TNF-αa | Partial correlation coefficient | |
| CRP (mg/L) 0.328 | |||||
| TNF-α (pg/ml) 0.373 | |||||
| IL-6 (pg/ml) 0.337 | |||||
| IL-1β (pg/ml) 0.326 | |||||
| IL-4 (pg/ml) 0.046 | |||||
| IL-10 (pg/ml) −0.333 | |||||
| 2018 | Ireland | 26 | Inflammatory score | Mean of < Median E-DII vs > Median E-DII | |
| 2018 | USA | 26 | CRP | OR (95%CI) | |
| 2018 | Germany | Not found | CRP | ||
| 2018 | Iran | 28 | CRP | Beta estimate (95%CI) for the association | |
| 2017 | Portugal | 31 | CRP | OR (95%CI) | |
| 2017 | USA | 38 | CRP | Percentage change (95%CI) | |
| 2017 | African | 31 | CRP | Percentile regression (95%CI) | |
| 2017 | Iran | 31 | CRP | Beta estimates (95%CI) | |
| 2017 | France | 36 | CRP | OR (95%CI) | |
| 2017 | European | 25 | CRP | Beta estimates (95%CI) | |
| 2017 | USA | 27 | CRP | OR (95%CI) | |
| 2017 | Sweden | 30 | CRP | Beta coefficients (95%CI) | |
| 2016 | Turkey | 25 | CRP | ||
| 2016 | USA | 28 | CRP | Beta coefficients (95%CI) | |
| 2016 | UK | 27 | CRP | CRPa T1 −0.13 ± 1.3 | |
| 2015 | USA | 32 | IL-6 | Beta coefficients (95%CI) | |
| 2015 | Belgians | 17 | CRP | OR (95%CI) | |
| 2014 | Luxembourg | 24 | CRP | ||
| 2014 | USA | Not found | CRP | OR (95%CI) | |
| 2013 | USA | 44 (24-hour | CRP | OR (95%CI) | |
C3, complement C3; C4, complement C4; CRP, C-reactive protein; DII, Dietary inflammatory index; HPFS, Health Professionals Follow-Up Study; IL, Interleukin; NHS-II, Nurses’ Health Study II; NSAIDs, non-steroidal anti-inflammatory drugs; sICAM, soluble intercellular cell adhesion molecule; sVCAM, soluble vascular cell adhesion molecule; TNF-α, Tumor Necrosis Factor-α; TNF-αR2, Tumor Necrosis Factor-α Receptor 2; WBC, white blood cell.